HNRNPA2B1 and cancer: PFS analysis observed that high expression of HNRNPA2B1 in 10 cancers resulted in cancer progression, including GBMLGG, LGG, CESC, LUAD, PRAD, LUSC, LIHC, UVM, ACC, KICH, and low expression of HNRNPA2B1 in OV with poor (Supplementary figure 1, Supplementary table 4).